Centessa Pharmaceuticals plc
CNTA$3.67B
Mid CapNASDAQBiotechnology🇺🇸North America114 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Apr 30, 2026
4wMarket Overview
Stock performance and key metrics
CNTA News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ORX750 | Phase 2 | Narcolepsy Type 1 | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply